. b. Peripheral blood (PB) counts of APL mice injected with Placebo (PBS), Vehicle+ATRA (ATRA), Vehicle+ATO (ATO), Vehicle+ATO+ATRA (ATO+ATRA), pVAX14+ATO or VAX14+ATO+ATRA on day 60 of protocol illustrated on Figure 1a . The normal range is delineated in grey; statistical analyses are on Table S2 , nonparametric, unpaired, two tailed, Mann-Whitney test was used to compare different groups. The Prism software was used for the t-test analysis. Figure S3 . Increased cytotoxic cells in pVAX14-treated mice. A cytotoxic CFSE-based assay was performed as previously described (14) and detailed in legend to Figure 2e . Spleen cells from each cohort was re-stimulated using irradiated APL cells for 4 days at 37 o C. 10 4 CFSElabelled APL bone marrow (BM) targets were incubated at the following E:T ratio: 25:1, 50:1, and 100:1. Effector cells of pVAX14+ATO+ATRA-treated mice have increased cytotoxicity against APL cells compared to effectors from Vehicle+ATO+ATRA-treated mice at an E:T of 100:1 (p<0.05) and at all the three ratios; n=3 mice were assayed in triplicate. A 2-tailed unpaired t-test statistical analysis was used.
